Tirilazad mesylate attenuates the accumulation of neutrophils in ischemic gerbil brain.
CNS Diseases Research, Upjohn Company, Kalamazoo, Michigan 49001.
L R
LR
Williams
J A
JA
Oostveen
D000818:Animals; D015415:Biomarkers; D001921:Brain / Q000187:drug effects / Q000473:pathology* / Q000503:physiopathology; D002470:Cell Survival / Q000187:drug effects; D003576:Electron Transport Complex IV / Q000032:analysis* / Q000378:metabolism; D016166:Free Radical Scavengers; D005849:Gerbillinae; D002546:Ischemic Attack, Transient / Q000473:pathology / Q000503:physiopathology*; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D009504:Neutrophils / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D011281:Pregnatrienes / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000473:pathology / Q000503:physiopathology*
D015415:Biomarkers; D016166:Free Radical Scavengers; D011281:Pregnatrienes; D003576:Electron Transport Complex IV; C053355:tirilazad